• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[髓母细胞瘤不同分子亚型中CD8 T淋巴细胞浸润的临床病理特征及其机制]

[Clinicopathological characteristics of the CD8 T lymphocytes infiltration and its mechanism in distinct molecular subtype of medulloblastoma].

作者信息

Chai Xiaodong, Sun Ziwen, Li Haishuang, Zhu Liangyi, Liu Xiaodan, Liu Yantao, Pei Fei, Chang Qing

机构信息

Department of Pathology, Peking University Third Hospital, Beijing 100191, China.

Department of Pathology, Peking University School of Basic Medical Sciences, Beijing 100191, China.

出版信息

Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Jun 18;56(3):512-518. doi: 10.19723/j.issn.1671-167X.2024.03.019.

DOI:10.19723/j.issn.1671-167X.2024.03.019
PMID:38864138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11167556/
Abstract

OBJECTIVE

To investigate the characteristics of the CD8 T cells infiltration from the 4 subtypes in medulloblastoma (MB), to analyze the relationship between CD8 T cells infiltration and prognosis, to study the function of C-X-C motif chemokine ligand 11 (CXCL11) and its receptor in CD8 T cells infiltration into tumors and to explore the potential mechanism, and to provide the necessary clinicopathological basis for exploring the immunotherapy of MB.

METHODS

In the study, 48 clinical MB samples (12 cases in each of 4 subtypes) were selected from the multiple medical center from 2012 to 2019. The transcriptomics analysis for the tumor of 48 clinical samples was conducted on the NanoString PanCancer IO360 Panel (NanoString Technologies). Immunohistochemistry (IHC) staining of formalin-fixed, paraffin-embedded sections from MB was carried out using CD8 primary antibody to analyze diffe-rential quantities of CD8 T cells in the MB four subtypes. Through bioinformatics analysis, the relationship between CD8T cells infiltration and prognosis of the patients and the expression differences of various chemokines in the different subtypes of MB were investigated. The expression of CXCR3 receptor on the surface of CD8T cells in MB was verified by double immunofluorescence staining, and the underlying molecular mechanism of CD8T cells infiltration into the tumor was explored.

RESULTS

The characteristic index of CD8T cells in the WNT subtype of MB was relatively high, suggesting that the number of CD8T cells in the WNT subtype was significantly higher than that in the other three subtypes, which was confirmed by CD8 immunohistochemical staining and Gene Expression Omnibus (GEO) database analysis by using R2 online data analysis platform. And the increase of CD8T cells infiltration was positively correlated with the patient survival. The expression level of CXCL11 in the WNT subtype MB was significantly higher than that of the other three subtypes. Immunofluorescence staining showed the presence of CXCL11 receptor, CXCR3, on the surface of CD8T cells, suggesting that the CD8T cells might be attracted to the MB microenvironment by CXCL11 through CXCR3.

CONCLUSION

The CD8T cells infiltrate more in the WNT subtype MB than other subtypes. The mechanism may be related to the activation of CXCL11-CXCR3 chemokine system, and the patients with more infiltration of CD8T cells in tumor have better prognosis. This finding may provide the necessary clinicopathological basis for the regulatory mechanism of CD8T cells infiltration in MB, and give a new potential therapeutic target for the future immunotherapy of MB.

摘要

目的

探讨髓母细胞瘤(MB)4种亚型中CD8 T细胞浸润的特征,分析CD8 T细胞浸润与预后的关系,研究C-X-C基序趋化因子配体11(CXCL11)及其受体在CD8 T细胞浸润肿瘤中的作用及潜在机制,为探索MB的免疫治疗提供必要的临床病理依据。

方法

本研究选取2012年至2019年多个医学中心的48例临床MB样本(4种亚型各12例)。对48例临床样本的肿瘤进行转录组学分析,采用NanoString PanCancer IO360 Panel(NanoString Technologies)。用CD8一抗对MB福尔马林固定、石蜡包埋切片进行免疫组织化学(IHC)染色,分析MB 4种亚型中CD8 T细胞的差异数量。通过生物信息学分析,研究CD8 T细胞浸润与患者预后的关系以及MB不同亚型中各种趋化因子的表达差异。通过双重免疫荧光染色验证MB中CD8 T细胞表面CXCR3受体的表达,探索CD8 T细胞浸润肿瘤的潜在分子机制。

结果

MB的WNT亚型中CD8 T细胞的特征性指标相对较高,提示WNT亚型中CD8 T细胞数量显著高于其他3种亚型,这通过CD8免疫组化染色及使用R2在线数据分析平台进行的基因表达综合数据库(GEO)分析得以证实。并且CD8 T细胞浸润增加与患者生存呈正相关。WNT亚型MB中CXCL11的表达水平显著高于其他3种亚型。免疫荧光染色显示CD8 T细胞表面存在CXCL11受体CXCR3,提示CD8 T细胞可能通过CXCR3被CXCL11吸引至MB微环境。

结论

WNT亚型MB中CD8 T细胞浸润多于其他亚型。其机制可能与CXCL11-CXCR3趋化因子系统的激活有关,肿瘤中CD8 T细胞浸润较多的患者预后较好。这一发现可能为MB中CD8 T细胞浸润的调控机制提供必要的临床病理依据,并为未来MB的免疫治疗提供新的潜在治疗靶点。

相似文献

1
[Clinicopathological characteristics of the CD8 T lymphocytes infiltration and its mechanism in distinct molecular subtype of medulloblastoma].[髓母细胞瘤不同分子亚型中CD8 T淋巴细胞浸润的临床病理特征及其机制]
Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Jun 18;56(3):512-518. doi: 10.19723/j.issn.1671-167X.2024.03.019.
2
Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4, CD8 T cells, and M1 macrophages.计划中的缺陷:miR-34a-5p 通过调节 CD4、CD8 T 细胞和 M1 巨噬细胞中的 CXCL10/CXCL11/CXCR3 轴来影响趋化因子信号。
J Immunother Cancer. 2020 Nov;8(2). doi: 10.1136/jitc-2020-001617.
3
CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.CXCR3 配体在癌症和自身免疫中的作用、效应 T 细胞的趋化作用及其他。
Front Immunol. 2020 May 29;11:976. doi: 10.3389/fimmu.2020.00976. eCollection 2020.
4
The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.靶向CXCR3的趋化因子CXCL11在体内具有强大的抗肿瘤活性,涉及吸引CD8 + T淋巴细胞,但不抑制血管生成。
J Immunother. 2005 Jul-Aug;28(4):343-51. doi: 10.1097/01.cji.0000165355.26795.27.
5
Cancer-cell-secreted CXCL11 promoted CD8 T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC.非小细胞肺癌中,肿瘤细胞分泌的 CXCL11 通过多西紫杉醇诱导的 HMGB1 释放促进 CD8+T 细胞浸润。
J Immunother Cancer. 2019 Feb 11;7(1):42. doi: 10.1186/s40425-019-0511-6.
6
High programmed cell death 1 ligand-1 expression: association with CD8+ T-cell infiltration and poor prognosis in human medulloblastoma.高程序性细胞死亡配体 1 表达:与人类髓母细胞瘤中 CD8+ T 细胞浸润和不良预后相关。
J Neurosurg. 2018 Mar;128(3):710-716. doi: 10.3171/2016.11.JNS16991. Epub 2017 May 5.
7
Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres.对髓母细胞瘤分子亚群的研究方法:在资源有限的中心,与免疫组织化学和荧光原位杂交相结合的 NanoString nCounter 检测方法的比较。
J Neurooncol. 2019 Jul;143(3):393-403. doi: 10.1007/s11060-019-03187-y. Epub 2019 May 18.
8
CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers.CXCL11-CXCR3 轴介导肿瘤淋巴管相互作用和炎症诱导的肿瘤促进途径在头颈部癌症中的作用。
Am J Pathol. 2020 Apr;190(4):900-915. doi: 10.1016/j.ajpath.2019.12.004. Epub 2020 Feb 5.
9
Exercise Training Improves Tumor Control by Increasing CD8 T-cell Infiltration via CXCR3 Signaling and Sensitizes Breast Cancer to Immune Checkpoint Blockade.运动训练通过 CXCR3 信号增加 CD8 T 细胞浸润来改善肿瘤控制,并使乳腺癌对免疫检查点阻断敏感。
Cancer Immunol Res. 2021 Jul;9(7):765-778. doi: 10.1158/2326-6066.CIR-20-0499. Epub 2021 Apr 10.
10
CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis.CXCL11 与免疫浸润相关,并影响患者免疫治疗疗效:泛癌分析。
Front Immunol. 2022 Jul 22;13:951247. doi: 10.3389/fimmu.2022.951247. eCollection 2022.

引用本文的文献

1
CD4 T cells correlate with better prognosis in medulloblastoma.在髓母细胞瘤中,CD4 T细胞与较好的预后相关。
Front Oncol. 2025 Jun 12;15:1593329. doi: 10.3389/fonc.2025.1593329. eCollection 2025.

本文引用的文献

1
CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma.载有 CXCL11 的溶瘤腺病毒增强 CAR-T 细胞治疗胶质母细胞瘤的疗效并重塑肿瘤微环境。
Mol Ther. 2023 Jan 4;31(1):134-153. doi: 10.1016/j.ymthe.2022.08.021. Epub 2022 Sep 2.
2
Radiation combined with KRAS-MEK inhibitors enhances anticancer immunity in KRAS-mutated tumor models.放疗联合KRAS-MEK抑制剂可增强KRAS突变肿瘤模型中的抗癌免疫力。
Transl Res. 2023 Feb;252:79-90. doi: 10.1016/j.trsl.2022.08.005. Epub 2022 Aug 7.
3
CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis.CXCL11 与免疫浸润相关,并影响患者免疫治疗疗效:泛癌分析。
Front Immunol. 2022 Jul 22;13:951247. doi: 10.3389/fimmu.2022.951247. eCollection 2022.
4
KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.KRAS-G12D 突变驱动免疫抑制和抗 PD-1/PD-L1 免疫疗法在非小细胞肺癌中的原发性耐药。
Cancer Commun (Lond). 2022 Sep;42(9):828-847. doi: 10.1002/cac2.12327. Epub 2022 Jul 11.
5
Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastoma.外泌体 microRNAs 通过 PPARγ 在 SHH 髓母细胞瘤的肿瘤进展过程中诱导肿瘤相关巨噬细胞。
Cancer Lett. 2022 Jun 1;535:215630. doi: 10.1016/j.canlet.2022.215630. Epub 2022 Mar 15.
6
Tumor-specific T cells support chemokine-driven spatial organization of intratumoral immune microaggregates needed for long survival.肿瘤特异性 T 细胞支持趋化因子驱动的肿瘤内免疫微聚集体的空间组织,这对于长期生存是必需的。
J Immunother Cancer. 2022 Feb;10(2). doi: 10.1136/jitc-2021-004346.
7
Strategies targeting tumor immune and stromal microenvironment and their clinical relevance.针对肿瘤免疫和基质微环境的策略及其临床相关性。
Adv Drug Deliv Rev. 2022 Apr;183:114137. doi: 10.1016/j.addr.2022.114137. Epub 2022 Feb 7.
8
Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade glioma.高等级脑胶质瘤中缺氧诱导的耗竭特征的空间免疫异质性。
Oncoimmunology. 2022 Jan 12;11(1):2026019. doi: 10.1080/2162402X.2022.2026019. eCollection 2022.
9
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.美国 2014-2018 年诊断的原发性脑和其他中枢神经系统肿瘤 CBTRUS 统计报告。
Neuro Oncol. 2021 Oct 5;23(12 Suppl 2):iii1-iii105. doi: 10.1093/neuonc/noab200.
10
CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment.CXCR6 将细胞毒性 T 细胞定位在肿瘤微环境中,以接收关键的存活信号。
Cell. 2021 Aug 19;184(17):4512-4530.e22. doi: 10.1016/j.cell.2021.07.015. Epub 2021 Aug 2.